Full Name
Masanori Hayashi
Job Title
Assistant Professor
Company
University of Colorado
Speaker Bio
Osteosarcoma liquid biopsies, the NPCF multi-center trial experience
Dr. Mas Hayashi is a physician scientist at the University of Colorado/Children’s Hospital Colorado leading a translationally focused laboratory research program in childhood sarcomas. His laboratory has been focused on the identification of novel anti-metastasis targets for sarcomas through the detection and interrogation of circulating tumor cells, as well as high-throughput screening methods. Combined with his expertise in developing novel blood tests of minimal residual disease through detection of circulating tumor DNA, his laboratory aims to change the current treatment paradigm by detecting metastasis early and treating metastasis differently to improve the cure rates of sarcomas. Dr. Hayashi is a graduate of Keio University School of Medicine in Tokyo and completed his pediatric residency training at Duke University, followed by his pediatric hematology/oncology training at the joint program of Johns Hopkins University and the National Cancer Institute.
Dr. Mas Hayashi is a physician scientist at the University of Colorado/Children’s Hospital Colorado leading a translationally focused laboratory research program in childhood sarcomas. His laboratory has been focused on the identification of novel anti-metastasis targets for sarcomas through the detection and interrogation of circulating tumor cells, as well as high-throughput screening methods. Combined with his expertise in developing novel blood tests of minimal residual disease through detection of circulating tumor DNA, his laboratory aims to change the current treatment paradigm by detecting metastasis early and treating metastasis differently to improve the cure rates of sarcomas. Dr. Hayashi is a graduate of Keio University School of Medicine in Tokyo and completed his pediatric residency training at Duke University, followed by his pediatric hematology/oncology training at the joint program of Johns Hopkins University and the National Cancer Institute.
Speaking At